Braidwell LP Day One Biopharmaceuticals, Inc. Transaction History
Braidwell LP
- $1.79 Billion
- Q4 2024
A detailed history of Braidwell LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Braidwell LP holds 4,873,853 shares of DAWN stock, worth $47.3 Million. This represents 3.46% of its overall portfolio holdings.
Number of Shares
4,873,853
Previous 4,873,853
-0.0%
Holding current value
$47.3 Million
Previous $67.9 Billion
99.91%
% of portfolio
3.46%
Previous 1.92%
Shares
8 transactions
Others Institutions Holding DAWN
# of Institutions
176Shares Held
77.8MCall Options Held
139KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$62.4 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$56.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$55.8 Million1.18% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$44 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.88MShares$37.7 Million0.01% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $713M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...